Larimar Therapeutics, Inc. (LRMR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2024 | $-1.32 | -57.1% |
| 2023 | $-0.84 | +38.7% |
| 2022 | $-1.37 | +53.6% |
| 2021 | $-2.95 | +17.4% |
| 2020 | $-3.57 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2024 | $-1.32 | -57.1% |
| 2023 | $-0.84 | +38.7% |
| 2022 | $-1.37 | +53.6% |
| 2021 | $-2.95 | +17.4% |
| 2020 | $-3.57 | — |